Metabolic syndrome
A new study has found a link between elevated liver enzymes and the risk of metabolic syndrome. The results, published in the journal, “Diabetes,” confirm what many experts have long suspected – that there is a connection between liver health and metabolic syndrome risk.
Nonalcoholic fatty liver disease is a major hepatic disorder in patients with metabolic syndrome and is the most common cause of abnormal liver function tests, including elevated liver enzymes.
The pathophysiology of nonalcoholic fatty liver disease is complex and involves alterations in lipid metabolism, insulin resistance, and inflammation. While the exact cause of nonalcoholic fatty liver disease in patients with metabolic syndrome is unknown, it is clear that elevated levels of free fatty acids and triglycerides play a central role in developing the disease.
Additionally, impaired insulin signaling and chronic inflammation contribute to nonalcoholic fatty liver disease progression in patients with metabolic syndrome. Treatment for elevated liver enzymes caused by metabolic syndrome typically focuses on lifestyle modification and addressing underlying conditions such as obesity and diabetes. In some cases, pharmacological therapy may also be employed.
